Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TC-5619 in Adults With ADHD
NCT01124708Phase 2Completed
- Sponsor
- Targacept
- Start
- May 2010
- Primary completion
- Feb 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of bradanicline in attention deficit hyperactivity disorder (ADHD), sponsored by Targacept. Started May 2010; status: completed.
02
Drugs
bradanicline
03
Conditions
attention deficit hyperactivity disorder (ADHD)
Beyond the preview
Go deeper on NCT01124708.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01124708.